ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,347, issued on Oct. 27, was assigned to NOILE-IMMUNE BIOTECH INC. (Tokyo).
"Isolated immune cell expressing a receptor, interleukin-7, and chemokine (C-C motif) ligand 19" was invented by Koji Tamada (Ube, Japan), Yukimi Sakoda (Ube, Japan) and Hidenobu Ishizaki (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides an isolated immune cell which expresses a receptor, interleukin-7, and chemokine (C-C motif) ligand 19."
The patent was filed on April 29, 2025, under Application No. 19/193,454.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...